Pages that link to "Q81213577"
Jump to navigation
Jump to search
The following pages link to FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides to enhance T-cell and natural killer cell function (Q81213577):
Displaying 16 items.
- Novel Immunotherapeutic Strategies of Gastric Cancer Treatment (Q27011232) (← links)
- Toll-like receptor 9 signaling by CpG-B oligodeoxynucleotides induces an apoptotic pathway in human chronic lymphocytic leukemia B cells (Q33931707) (← links)
- Outlining novel cellular adjuvant products for therapeutic vaccines against cancer (Q33997622) (← links)
- Age-related Defects in Ocular and Nasal Mucosal Immune System and the Immunopathology of Dry Eye Disease (Q35773063) (← links)
- Addition of CpG ODN and Poly (I:C) to a standard maturation cocktail generates monocyte-derived dendritic cells and induces a potent Th1 polarization with migratory capacity (Q35887255) (← links)
- Immune restoration following hematopoietic stem cell transplantation: an evolving target (Q36075296) (← links)
- Natural killer cell-directed therapies: moving from unexpected results to successful strategies (Q37143139) (← links)
- Human skin dendritic cells in health and disease (Q38258710) (← links)
- Dendritic Cell Recovery Impacts Outcomes after Umbilical Cord Blood and Sibling Donor Transplantation for Hematologic Malignancies. (Q38669334) (← links)
- Flt3 ligand enhances anti-tumor effects of antibody therapeutics (Q39412301) (← links)
- Immune adjuvant efficacy of CpG oligonucleotide in cancer treatment is founded specifically upon TLR9 function in plasmacytoid dendritic cells (Q39501063) (← links)
- Interleukin (IL)-15 in combination with IL-2, fms-like tyrosine kinase-3 ligand and anti-CD3 significantly enhances umbilical cord blood natural killer (NK) cell and NK-cell subset expansion and NK function (Q39574780) (← links)
- Translational Research Working Group developmental pathway for immune response modifiers. (Q40046843) (← links)
- An alternative flow cytometry strategy for peripheral blood dendritic cell enumeration in the setting of repetitive GM-CSF dosing (Q42532865) (← links)
- Recombinant DNA vaccine of the early secreted antigen ESAT-6 by Mycobacterium tuberculosis and Flt3 ligand enhanced the cell-mediated immunity in mice (Q51695717) (← links)
- Patients with FLT3-mutant AML needed to enroll on FLT3-targeted therapeutic clinical trials (Q91801421) (← links)